Bente Mikkelsen, Director Global Engagement Strategies at St. Jude Children’s Research Hospital, shared a post on LinkedIn:
“Thank you Catharina Boehme, the Government of Sri Lanka and Rajesh Pandav for this great commitment to childrenwithcancer and to the St. Jude Children’s Research Hospital and World Health Organization initiative with partners from UNICEF and PAHO Procurement and Supply Management to give access to childhood cancer medicines. The GPCCAM is an innovative and most needed intervention to save children with cancer. Without government leadership the dream that no child in its dawn of life should die would not come through!”
Quoting Catharina Boehme, Assistant Director of General External Relations at the World Health Organization, on LinkedIn:
“Excited to see Sri Lanka join the Global Platform for Access to Childhood Cancer Medicines!
The Global Platform aims to provide an uninterrupted supply of quality-assured cancer medicines to approximately 120 000 children in low- and middle-income countries in the next five to seven years. And the goal to reduce mortality by 60%.
This announcement brings us one step closer to ensuring every child in Sri Lanka has access to the quality-assured cancer medicines they need to survive and thrive.
The collaboration will strengthen supply chains, improve treatment continuity, and build health system capacity. It’s country-led action like this that transforms global commitments into real impact for children and families.
We at the World Health Organization South-East Asia are grateful to our partners at St. Jude, UNICEF, PAHO and to Sri Lanka’s Ministry of Health for their leadership. Together, we’re making progress toward a world where no child dies from a treatable cancer.
Congratulations to our WHO Representative in Sri Lanka Rajesh Pandav, thank you for your leadership in making this possible.
Also, I couldn’t be happier to mark this day in the company of Bente Mikkelsen.”
Other articles featuring Bente Mikkelsen and Catharina Boehme on OncoDaily.
